Dr. Grabowski Explains the Effects of Enzyme Therapy

Video

Dr. Gregory A. Grabowski from Cincinnati Children's Hospital Medical Center Explains the Effects of Enzyme Therapy

Gregory A. Grabowski, MD, professor, University Cincinnati, Department of Pediatrics, director, Division of Human Genetics, director, Medical Genetics Training Program, Cincinnati Children's Hospital Medical Center, discusses the immense benefit that enzyme therapy provides to patients with Gaucher disease, a debilitating lysosomal storage disease.

The dramatic benefits of enzyme therapy became increasingly evident 5 years after the therapy came into the market. While delivering a talk at a patient conference Grabowski recalls noticing the shift in the appearance of the patients; they no longer carried crutches and looked healthy. The way patients looked before enzyme therapy was gone and would remain gone.

Although the costs are a concern the benefits of the treatment is remarkable. He heralds the Gaucher disease enzyme treatment as amazing with very few problems associated with the treatment.

Grabowski remarks that it is an amazing experience to see patients get better. In the past 20 years he’s witnessed 1200-1300 patients become healthy after receiving the treatment. The comparison of benefits between the enzyme therapy and the supportive therapies used before is remarkable and is a total transformation in healthcare.

Related Videos
Emmanuel Antonarakis, MD, associate director, Translational Research, Masonic Cancer Center, University of Minnesota, Clark Endowed Professor of Medicine, University of Minnesota Medical School
Ricardo D. Parrondo, MD, hematologist/oncologist, Mayo Clinic
Ilyas Sahin, MD
Raj Singh, MD
Jaime R. Merchán, MD, professor, co-leader, Translational and Clinical Oncology Research Program, director, Phase 1 Clinical Trials Program, Department of Medicine, Division of Medical Oncology, the University of Miami Miller School of Medicine, Sylvester Comprehensive Cancer Center
Saad J. Kenderian, MB, CHB
Tycel Phillips, MD
Minesh Mehta, MD
Corey Cutler, MD, MPH, and Hana Safah, MD, experts on GvHD
Shivaani Kummar, MBBS, FACP, Margaret and Lester DeArmond Endowed Chair of Cancer Research, Professor and Division Head, Division of Hematology/Medical Oncology, Oregon Health & Science University School of Medicine; co-director, Center for Experimental Therapeutics, co-deputy director, Knight Cancer Institute